Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of cas 199477-18-4 gaggvgksal in China, also supports custom service. Welcome to wholesale bulk high quality cas 199477-18-4 gaggvgksal from our factory. Contact us for more details.
| Description | The nonamer GAGGVGKSAL, an HLA-A2-restricted CD8+ epitope; used for tetramer staining and CTL immune monitoring. |
Product Basic Information Table
| Product Standard English Name | Product Abbreviation / Alias | Function Tags (comma-separated) | Core Structure | Molecular Formula | Exact Mass (Da) | Average MW (Da) | Salt Form | Length (aa) |
| KRAS WT (10-19) GAGGVGKSAL | KRAS WT 10-19, GAGGVGKSAL, Gly-Ala-Gly-Gly-Val-Gly-Lys-Ser-Ala-Leu, wild-type control vs G12D mutant, CAS 199477-18-4 | KRAS, wild-type, control peptide, neoantigen, epitope peptide, tumor immunotherapy | H-Gly-Ala-Gly-Gly-Val-Gly-Lys-Ser-Ala-Leu-OH (linear 10-mer, all neutral/hydrophilic residues) | C34H61N11O12 | 815.45 | 815.92 | Per supplier COA (commonly TFA salt; formula calculated for free peptide) | 10 |
Physicochemical Solubility & Storage Parameters
| Product Code | Appearance | Long-term Storage | Short-term Storage | Solution Stability | Solid Powder Stability |
| PEP-KRASWT19-01 | White to off-white powder | Store desiccated and sealed at -20°C | Short-term storage at 2-8°C; aliquot and freeze working solutions | No Cys/Met/Trp/Tyr-sensitive residues, good stability; contains Lys/Ser/Gly with good water solubility (GenScript: soluble in ultrapure water up to ~1 mg/mL or less), DMSO may be used for assistance; net charge ~+1 (1 Lys) | powder is stable when desiccated and sealed; protect from moisture; after opening, aliquot promptly and keep in a desiccator |
Functional Description
| Product Code | Frontend Short Summary | Detailed Biological Function Description | Applicable Research Areas (comma-separated) | Targets / Receptors |
| PEP-KRASWT19-01 | The human KRAS wild-type 10-19 decapeptide GAGGVGKSAL (CAS 199477-18-4) corresponds to residues 10-19 at the N-terminus of KRAS (position 12 being the native Gly) and serves as the matched wild-type control peptide for the G12D mutant peptide (GADGVGKSAL) in tumor neoantigen research. | KRAS is one of the most frequently mutated human oncogenes; codon-12 mutations (e.g., G12D) occur in pancreatic, colorectal and lung cancers, making KRAS-derived neoantigen vaccines and TCR/TIL discovery a major focus of tumor immunotherapy. This product, GAGGVGKSAL, is the wild-type 10-19 decapeptide of human KRAS (UniProt P01116) with the native Gly at position 12. It is used in parallel with the G12D mutant peptide (GADGVGKSAL; Gly→Asp at position 12) to assess TCR/antibody selectivity for the mutant epitope and differences in HLA presentation. Applications include KRAS neoantigen vaccine research, specificity control for mutant peptides, and tumor immunotherapy development. | Tumor neoantigen, KRAS wild-type control, immunotherapy, TCR/TIL discovery, mutant-peptide specificity control | MHC class I molecules (control vs G12D mutant peptide); KRAS-specific T-cell receptors (TCR) |
Hot Tags: cas 199477-18-4 gaggvgksal, China cas 199477-18-4 gaggvgksal manufacturers, suppliers, factory, cateninpeptide, 124454-83-7, 265669-37-2, CAS 124454 83 7, CAS 265669 37 2, epitope peptides
